The plastic bottle that became a Parkinson's drug

Plastic waste is becoming an increasing problem, with 50 million tonnes of single-use plastic being produced each year. Plastics are used in the packaging of food and drinks.
Las Vegas Sun

AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...

Cue Biopharma, Inc.: Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness -CUE-401 is the Company's lead asset for the treatment of autoimmune and inflammatory diseasesAppointed indust ...

The Peptide Boom Is Getting Out of Hand

In the cases of weight loss and erectile dysfunction, more patients are getting the care they want or need. I personally ...

Roche Bought Thousands Of Nvidia AI Chips To Speed Up Drug Development

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...
The Manila Times

Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Presented in vivo and in vitro data that demonstrate the therapeutic potential of CUE-401 to restore immune balance for the ...
Frontiers

Generative AI in Chemistry: Bridging Computational Strategies with Practical Applications in Medicinal Innovation

The application of artificial intelligence (AI) in drug discovery is revolutionizing the field, offering unprecedented opportunities for accelerating the ...

Plastic bottles transformed into Parkinson's drug using bacteria

A drug to treat Parkinson's disease can be made from waste plastic bottles using a pioneering method, a study shows. The approach harnesses the power of bacteria to transform post-consumer plastic ...
Science Daily

A lab mistake at Cambridge reveals a powerful new way to modify drug molecules

Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...
Healio

FDA efforts to reduce animal testing signal shift toward AI, organ-on-chip study methods

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
Frontiers

Organoids, Assembloids and Organ-on-a-Chip Systems for Transformative Drug Development

Organoids, assembloids, and organ-on-a-chip technologies represent transformative advances in the fields of drug discovery, precision medicine, and ...

Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...